File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Immune Cell Associations with Cancer Risk

TitleImmune Cell Associations with Cancer Risk
Authors
KeywordsCancer
Immunology
Cancer Systems Biology
Issue Date2020
Citation
iScience, 2020, v. 23, n. 7, article no. 101296 How to Cite?
AbstractProper immune system function hinders cancer development, but little is known about whether genetic variants linked to cancer risk alter immune cells. Here, we report 57 cancer risk loci associated with differences in immune and/or stromal cell contents in the corresponding tissue. Predicted target genes show expression and regulatory associations with immune features. Polygenic risk scores also reveal associations with immune and/or stromal cell contents, and breast cancer scores show consistent results in normal and tumor tissue. SH2B3 links peripheral alterations of several immune cell types to the risk of this malignancy. Pleiotropic SH2B3 variants are associated with breast cancer risk in BRCA1/2 mutation carriers. A retrospective case-cohort study indicates a positive association between blood counts of basophils, leukocytes, and monocytes and age at breast cancer diagnosis. These findings broaden our knowledge of the role of the immune system in cancer and highlight promising prevention strategies for individuals at high risk.
Persistent Identifierhttp://hdl.handle.net/10722/292215
PubMed Central ID
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorPalomero, Luis-
dc.contributor.authorGalván-Femenía, Ivan-
dc.contributor.authorde Cid, Rafael-
dc.contributor.authorEspín, Roderic-
dc.contributor.authorBarnes, Daniel R.-
dc.contributor.authorCIMBA-
dc.contributor.authorBlommaert, Eline-
dc.contributor.authorGil-Gil, Miguel-
dc.contributor.authorFalo, Catalina-
dc.contributor.authorStradella, Agostina-
dc.contributor.authorOuchi, Dan-
dc.contributor.authorRoso-Llorach, Albert-
dc.contributor.authorViolan, Concepció-
dc.contributor.authorPeña-Chilet, María-
dc.contributor.authorDopazo, Joaquín-
dc.contributor.authorExtremera, Ana Isabel-
dc.contributor.authorGarcía-Valero, Mar-
dc.contributor.authorHerranz, Carmen-
dc.contributor.authorMateo, Francesca-
dc.contributor.authorMereu, Elisabetta-
dc.contributor.authorBeesley, Jonathan-
dc.contributor.authorChenevix-Trench, Georgia-
dc.contributor.authorRoux, Cecilia-
dc.contributor.authorMak, Tak-
dc.contributor.authorBrunet, Joan-
dc.contributor.authorHakem, Razq-
dc.contributor.authorGorrini, Chiara-
dc.contributor.authorAntoniou, Antonis C.-
dc.contributor.authorLázaro, Conxi-
dc.contributor.authorPujana, Miquel Angel-
dc.date.accessioned2020-11-17T14:56:00Z-
dc.date.available2020-11-17T14:56:00Z-
dc.date.issued2020-
dc.identifier.citationiScience, 2020, v. 23, n. 7, article no. 101296-
dc.identifier.urihttp://hdl.handle.net/10722/292215-
dc.description.abstractProper immune system function hinders cancer development, but little is known about whether genetic variants linked to cancer risk alter immune cells. Here, we report 57 cancer risk loci associated with differences in immune and/or stromal cell contents in the corresponding tissue. Predicted target genes show expression and regulatory associations with immune features. Polygenic risk scores also reveal associations with immune and/or stromal cell contents, and breast cancer scores show consistent results in normal and tumor tissue. SH2B3 links peripheral alterations of several immune cell types to the risk of this malignancy. Pleiotropic SH2B3 variants are associated with breast cancer risk in BRCA1/2 mutation carriers. A retrospective case-cohort study indicates a positive association between blood counts of basophils, leukocytes, and monocytes and age at breast cancer diagnosis. These findings broaden our knowledge of the role of the immune system in cancer and highlight promising prevention strategies for individuals at high risk.-
dc.languageeng-
dc.relation.ispartofiScience-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectCancer-
dc.subjectImmunology-
dc.subjectCancer Systems Biology-
dc.titleImmune Cell Associations with Cancer Risk-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.isci.2020.101296-
dc.identifier.pmid32622267-
dc.identifier.pmcidPMC7334419-
dc.identifier.scopuseid_2-s2.0-85087217927-
dc.identifier.volume23-
dc.identifier.issue7-
dc.identifier.spagearticle no. 101296-
dc.identifier.epagearticle no. 101296-
dc.identifier.eissn2589-0042-
dc.identifier.isiWOS:000553389400005-
dc.identifier.issnl2589-0042-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats